Allomap and allosure post heart transplant rejection surveillance tests services
Active Definitive Contract Awarded Last action
- Contract number
- 36C26122C0017
- Awardee
-
Caredx, Inc. UEI Y371A27ZEUM4
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,250,323
Award facts
- Opportunity
-
- Q515--AlloMap and AlloSure post transplant rejection surveillance tests Pre-Solicitation · 36C26121Q1193 · Posted Sep 9, 2021
- Contract value 100% obligated
- $1,250,322.79 Current and potential, with all options
- Completion date 94% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q515 Medical- Pathology
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Brisbane, CA 94005, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Additional Work (new agreement, FAR part 6 applies) | $184,663 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $138,498 | |
| Supplemental Agreement for work within scope | $106,098 | |
| Exercise an Option | $138,498 | |
| Additional Work (new agreement, FAR part 6 applies) | $161,161 | |
| Supplemental Agreement for work within scope | $118,235 | |
| Exercise an Option | $138,498 | |
| Funding Only Action | -$12,322 | |
| Exercise an Option | $138,498 | |
| Original award | $138,498 |
Show all 11
About this award
Veterans Integrated Service Network 21 awarded a $1.25 million definitive contract to CareDx, Inc. for AlloMap and AlloSure post-heart transplant rejection surveillance tests on March 1, 2022, under full-and-open competition with no set-aside.
The originating solicitation, posted September 9, 2021, sought five-year indefinite-delivery services to deliver approximately 30 AlloMap and 15 AlloSure blood tests annually to heart transplant recipients in the Palo Alto, California area. The contract structure provides a five-year base through February 28, 2027, with four one-year option periods. Place of performance is Brisbane, CA. The services support post-transplant organ rejection surveillance and immunosuppression monitoring for veteran beneficiaries.
Quick answers
Who was awarded contract 36C26122C0017?
36C26122C0017 was awarded to Caredx, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on March 1, 2022.
How much is contract 36C26122C0017 worth?
The government has obligated $1,250,323 on 36C26122C0017.
Was contract 36C26122C0017 competed?
The extent of competition for 36C26122C0017 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award